Literature DB >> 33532627

Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature.

Navid Tabriz1, Arved Gruben1, Verena Uslar1, Dirk Weyhe1.   

Abstract

Introduction: We investigated known (eg age, smoking, thyrotropin receptor autoantibody (TRAb)) and new risk factors (eg thyroid peroxidase autoantibodies (TPO-Ab), thyroid size, or BMI) for Graves' disease (GD) and Graves' orbitopathy (GO), especially in combination with each other, to determine which factors play the most important role in the development of GO.
Methods: From 2008 to 2018, n = 500 patients with GD were included in this retrospective single-centre case-control study. N = 231 (46%) had a GO and n = 269 (54%) showed no GO. Differences in risk factors were determined by Mann-Whitney U and chi-square test. Combined influences of factors were examined by multivariable logistic regression.
Results: Age at first diagnosis of GD (OR = 1.043, p < .006), smoking status (OR = 2.64, p < .026) and TRAb (OR = 1.046, p < .01) had a significant impact on GO. The factors gender, TPO-Ab titre, BMI, TSH titre, T3 and T4 were not significant.
Conclusion: As it has been shown in univariate analyses, smoking, age and TRAb levels have a negative impact on the onset and course of GD and GO. Via multivariable regression, we could additionally show that smoking is the most important factor out of those analysed. TRAb might be a helpful surrogate parameter in the assessment of the progress of GO and therefore might be one factor in the decision-making process for potential early operative surgery. With regard to the hitherto unclear role of BMI, thyroid size and TPO-Ab in the course of GO, this study could not find any clinically relevant influence.
© 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Graves' disease; TRAb; multivariable analysis; thyroid surgery

Year:  2020        PMID: 33532627      PMCID: PMC7831207          DOI: 10.1002/edm2.210

Source DB:  PubMed          Journal:  Endocrinol Diabetes Metab        ISSN: 2398-9238


  28 in total

1.  Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.

Authors:  Jwu Jin Khong; Sue Finch; Chamika De Silva; Stacey Rylander; Jamie E Craig; Dinesh Selva; Peter R Ebeling
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

Review 2.  Graves' ophthalmopathy: current concepts regarding pathogenesis and management.

Authors:  H B Burch; L Wartofsky
Journal:  Endocr Rev       Date:  1993-12       Impact factor: 19.871

Review 3.  Cigarette smoking and thyroid eye disease: a systematic review.

Authors:  J Thornton; S P Kelly; R A Harrison; R Edwards
Journal:  Eye (Lond)       Date:  2006-09-15       Impact factor: 3.775

4.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; F Bogazzi; L Manetti; M L Tanda; E Dell'Unto; G Bruno-Bossio; M Nardi; M P Bartolomei; A Lepri; G Rossi; E Martino; A Pinchera
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

5.  The initial clinical characteristics of Graves' orbitopathy vary with age and sex.

Authors:  D L Kendler; J Lippa; J Rootman
Journal:  Arch Ophthalmol       Date:  1993-02

6.  Smoking and risk of Graves' disease.

Authors:  M F Prummel; W M Wiersinga
Journal:  JAMA       Date:  1993-01-27       Impact factor: 56.272

7.  High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.

Authors:  Elena Sabini; Barbara Mazzi; Maria Antonietta Profilo; Teresa Mautone; Giamberto Casini; Roberto Rocchi; Ilaria Ionni; Francesca Menconi; Marenza Leo; Marco Nardi; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Thyroid       Date:  2018-02-09       Impact factor: 6.568

8.  Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.

Authors:  Austin Gibson; Atman Dave; Craig Johnson; Anupam Kotwal; Abbey L Fingeret
Journal:  J Surg Res       Date:  2020-08-13       Impact factor: 2.192

9.  Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy.

Authors:  Jung Hyun Lee; So Hyun Park; Dae Gyun Koh; Byung Kyu Suh
Journal:  World J Pediatr       Date:  2014-03-25       Impact factor: 2.764

10.  Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.

Authors:  P Perros; L Hegedüs; L Bartalena; C Marcocci; G J Kahaly; L Baldeschi; M Salvi; J H Lazarus; A Eckstein; S Pitz; K Boboridis; P Anagnostis; G Ayvaz; A Boschi; T H Brix; N Currò; O Konuk; M Marinò; A L Mitchell; B Stankovic; F B Törüner; G von Arx; M Zarković; W M Wiersinga
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

View more
  1 in total

Review 1.  Quality of Life in Patients with Benign Non-Toxic Goiter After Surgical Intervention: A Systematic Review and Meta-Analysis.

Authors:  Natalia Chaves; M Juanita Rodriguez; Jordan M Broekhuis; Hao Wei Chen; Paul A Bain; Benjamin C James
Journal:  World J Surg       Date:  2022-01-24       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.